Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02691962 · ClinicalTrials.gov registry record · NA
Xen Matrix™ AB Surgical Graft in Ventral or Incisional Midline Hernias
A NA study, sponsored by C. R. Bard.
- Completed
- Registry status
- NA
- Development phase
- 75
- Enrollment target
NCT02691962: Completed NA study, sponsored by C. R. Bard.
NCT02691962 is a NA study that has completed, run by C. R. Bard. The registered enrollment target is 75 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02691962, a NA study, has completed, sponsored by C. R. Bard.
- COMPLETED
- Registry status
- NA
- Development phase
- 75 participants
- Enrollment target
Study Summary
This study aims to prospectively explore the use of XenMatrix™ AB Surgical Graft for ventral or incisional midline hernia repair in patients across all wound classes ("All Comers") through 24 months post repair.
Primary Outcome
Wound occurrences were defined as surgical site infection, seroma, wound dehiscence, skin necrosis and fistulas requiring intervention.
Interventions
- DEVICE Xen Matrix AB
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 75 participants |
| Start Date | 2016-05 |
| Est. Completion | 2020-05 |
| Phase | NA |
What the finished NCT02691962 record still lists
NCT02691962 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 75 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower).
The record links to 0 conditions, and to 1 intervention - of which Xen Matrix AB is the first listed.
NCT02691962 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02691962 about?
NCT02691962 is a clinical study titled "Xen Matrix™ AB Surgical Graft in Ventral or Incisional Midline Hernias". This study aims to prospectively explore the use of XenMatrix™ AB Surgical Graft for ventral or incisional midline hernia repair in patients across all wound classes ("All Comers") through 24 months post repair.
What is the current status of trial NCT02691962?
This trial is currently completed. It is a NA study. The enrollment target is 75 participants. The study started on 2016-05. Estimated completion is 2020-05.
What interventions are being tested in trial NCT02691962?
The interventions under investigation include: Xen Matrix AB (DEVICE).
Who is sponsoring clinical trial NCT02691962?
This trial is sponsored by C. R. Bard, which has 75 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02691962's enrollment target sits among peer trials
75 1069th of 2000 higher than 919 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01535430 · 75 participants
Assessment of Eloquent Function in Brain Tumor Patients
- NCT01542879 · 75 participants · Phase 1
Development of Radiation Free Whole Body Magnetic Resonance (MR) Imaging Technique for Staging Children With Cancer
- NCT02232191 · 75 participants · Phase 2
Immunologic Response to Pneumococcal Polysaccharide Vaccine in Splenic Injury Patients
- NCT02754544 · 75 participants · NA
Electrocorticography in Mapping Functional Brain Areas During Surgery in Patients With Brain Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia